Helikon Investments raises Abivax stake to 6.22%
ABVX•Helikon Investments held 6.22% of Abivax’s capital, or 5,426,529 shares, and 6.13% of its voting rights on October 8, 2026.
1. Stake disclosure
Helikon Investments held 6.22% of Abivax’s capital, representing 6.13% of voting rights, on October 8, 2026. The holding totaled 5,426,529 shares for its Helikon Long Short Equity Fund Master ICAV. Market purchases lifted the capital stake above 5% on September 24 and voting rights above 5% on September 25.
